XML 14 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 164,671 $ 143,228
Short-term marketable securities 773,160 379,574
Accounts receivable, net 41,017 47,986
Inventory 20,354 15,181
Prepaid expenses and other current assets 11,101 11,389
Total current assets 1,010,303 597,358
Long-term marketable securities 146,118 268,783
Property and equipment, net 56,995 43,668
Right-of-use assets 38,503 29,140
Intangible assets, net 17,148 8,524
Goodwill 3,290 3,290
Capitalized license fees 55 6,890
Other assets 5,124 4,882
Total Assets [1] 1,277,536 962,535
Current liabilities:    
Accounts payable 15,982 16,197
Accrued compensation 18,526 18,557
Accrued expenses 24,055 25,703
Deferred revenue 11,485 12,277
Total current liabilities 70,048 72,734
Long-term operating lease liabilities 41,117 33,256
Obligation related to royalty 0 6,880
Other long-term liabilities 1,382 1,672
Total Liabilities [1] 112,547 114,542
Redeemable noncontrolling interest 50,400 49,600
Stockholders’ equity:    
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of June 30, 2020 and December 31, 2019; 99,312,237 and 94,261,414 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively 1 1
Additional paid-in capital 1,544,373 1,150,090
Accumulated other comprehensive income 5,392 1,111
Accumulated deficit (435,177) (352,809)
Total Stockholders’ Equity 1,114,589 798,393
Total Liabilities, Redeemable Noncontrolling Interest and Stockholders’ Equity $ 1,277,536 $ 962,535
[1] As of June 30, 2020 and December 31, 2019, includes $38.4 million and $45.1 million of assets, respectively, that can be used only to settle obligations of the consolidated variable interest entity (“VIE”) and VIE’s subsidiaries, and $4.0 million and $5.7 million of liabilities of the consolidated VIE and VIE’s subsidiaries, respectively, for which their creditors do not have recourse to the general credit of the Company. See Note 3, Investment in Joint Venture.